Small Business Resources, Business Advice and Forms from AllBusiness.com
 

Cougar Biotechnology Appoints Vice President of Finance.

LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced the appointment of Charles R. Eyler as Vice President of Finance. Mr. Eyler brings more than 20 years of experience in financial management and leadership for healthcare related companies to his new

role at Cougar.

"Charles' substantial experience in building and managing the financial infrastructure within a number of different healthcare companies will be extremely valuable to Cougar at this stage of the Company's growth," said Dr. Arie Belldegrun, MD, FACS, Vice Chairman of the Board of Directors of Cougar Biotechnology. "The broad depth of Charles' financial experience and knowledge will be an important asset to Cougar," added Alan H. Auerbach, Chief Executive Officer and President of Cougar Biotechnology. "We look forward to Charles' contribution to the management team at Cougar."

Prior to joining Cougar, Mr. Eyler served as Chief Financial Officer and Chief Operating Officer of Hayes Medical Inc from 1999 to 2004. Prior to Hayes Medical, Mr. Eyler held several financial positions including Director of Finance and Administration at Alphatec Manufacturing, Inc., Division Controller at JBL Scientific, Inc., Division Controller at Surgitek, Inc. and Financial Systems Director at Zimmer, Inc. He holds a BS from Drexel University and an MBA from Saint Francis College.

About Cougar Biotechnology

Cougar Biotechnology, Inc. is a Los Angeles-based private biotechnology company established to in-license and develop early clinical stage drugs, with a specific focus on the field of oncology. Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com.

In addition, make sure to read these articles:

  • Cougar Biotechnology Appoints Vice President...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced the appointment of Gloria Lee, M.D., Ph.D. as Vice President of Clinical ......
  • California Association of Physician Groups...
  • LOS ANGELES -- The California Association of Physician Groups (CAPG) today announced the appointment of Richard Swanson to the position of vice president. In ......
  • New Chief Executive Named for USC University...
  • Business Editors & Health/Medical Writers LOS ANGELES--(BUSINESS WIRE)--Sept. 18, 2000 Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Paul S. Viviano as chief executive ......
  • Weekly top gainers.
  • WEEKLY TOP GAINERS TOP TEN GAINERS BY PERCENTAGE May 30 May 23 Price Company Close Close Change Compumed Inc. $0.65 $0.29 $0.36 Global e-Point Inc....
  • Weekly top gainers.
  • WEEKLY TOP GAINERS TOP TEN GAINERS BY PERCENTAGE Oct. 10 Oct. 3 Price Company Close Close Change Patient Safety Technologies Inc. $1.73 $1.35 $0.38 ......
  • A T M I Announces Systems Division Controller;...
  • Business/Technology Editors DANBURY, Conn.--(BUSINESS WIRE)--May 18, 2000 A T M I Inc. (Nasdaq:ATMI), today announced that Don Taylor has joined A T M I's Systems ......
  • Cougar Biotechnology Licenses Rights to...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that it has licensed the worldwide, exclusive rights to seocalcitol (EB1089) ......
  • Cougar Biotechnology Announces Approval of IND...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that its Investigational New Drug (IND) application for the Company's drug ......
  • Cougar Biotechnology to Present at Cowen & Co.
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, ......
  • Cougar Biotechnology to Present at SoCalBio...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, ......
  • Cougar Biotechnology Announces Initiation of...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that the first patient has been enrolled in the Phase I/II ......
  • Cougar Biotechnology Announces Acceptance of CTA...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a privately held biotechnology company, today announced that its Clinical Trial Authorization (CTA) for the Company's drug CB7630 ......
  • Research and Markets: Jim Sherblom brings...
  • DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36476) has announced the addition of Biotechnology Company Valuations & Exit Strategies - Video Leadership Seminar With James ......
  • Business Alliance Team of Biotechnology Company,...
  • Business Editors & Health/Medical Writers BIOWIRE2K DEN BOSCH, Netherlands--(BW HealthWire)--Oct. 26, 2001 J.A.M. (Hans) van Beek (40) PhD. is recently appointed as Vice President Business ......
  • Cougar Biotechnology Announces Presentation at...
  • LOS ANGELES -- Cougar Biotechnology, Inc., a publicly held biotechnology company, today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, ......
Find great franshise opportunities that fit your budget. Start your search today!
Industry Type:
Area of Interest:
Liquid Capital: